Resilience

Resilience CEO Rahul Singhvi will attend the #Bioprocessing Venture, Innovation and Partnering Conference as a panelist on August 21 in Boston, MA. He and other industry leaders will be discussing biomanufacturing innovation and collaboration models. Register below to join and hear more about this important topic. https://hubs.ly/Q02Gq_TM0

Rapidly reaching first-in-human studies can be challenging. Partnering with an experienced CDMO who supports clinical and commercial programs, leverages process and tech transfer expertise, and offers growing capacity for fed-batch programs at any stage of development, can help ease the path forward. And we don’t stop there.   Learn how we can help support your next biologics program: https://hubs.ly/Q02G426l0 #biologics #biologicsdevelopment

↕️ Determining the right fit for your contract manufacturing needs is a pivotal step in getting your product to market sooner. Try our CDMO partnership on for size with our on demand fill/finish capacity update presentation: https://hubs.ly/Q02DTlcZ0

Speed is a necessity. How are Resilience teams developing platforms to accelerate vector development & manufacturing? Learn from Xiaotong Fu, our Head of Downstream Process Development and Pilot Operations, as he shares how his team leverages modular platforms and collaborations with our GMP Manufacturing team to ensure Resilience can deliver a GMP batch of viral vector in 12 months or less. Watch the full interview on our blog: https://hubs.ly/Q02DCgGl0

🇺🇸On this Independence Day, we pause to honor the bravery and vision of those who fought for our nation's freedom. At Resilience, these enduring values of liberty continue to inspire us. As we celebrate this 4th of July, we wish everyone a meaningful and joyful holiday. #IndependenceDay #July4th #USA

Growth can be exciting, but daunting. And there’s no template that demonstrates the step-by-step route of getting your product to the market, because your innovation is unique and blazing its own trail. With Sprout Solutions, discover how we can take the foundation you’ve invested in and identify the building blocks, framework, scale-up, and manufacturing that naturally come next. Complete our innovative questionnaire to receive a custom list of resources to help grow your drug substance from a small sprout all the way to market and which steps could be most effectively accomplished through a partnership with a CDMO: https://hubs.ly/Q02xMmY-0

🔎 Looking for a CDMO drug product partner? Check out our on-demand fill/finish capacity update presentation with Evan Pasenello: https://hubs.ly/Q02DTqL50

Today, we celebrate the beauty, diversity, and rich history of the great country of Canada – Home to our Toronto facility! Wishing everyone a safe and enjoyable holiday with friends and family. #CanadaDay #CelebrateCanada

Resilience is proud to announce that our Cincinnati, Ohio site has recently earned ISO 13485 Certification. ISO 13485 is an internationally recognized standard that establishes requirements for a quality management system (QMS) for organizations that provide medical devices and related services. This certification for the site under Resilience’s leadership showcases our commitment to quality and regulatory compliance to remain as a competent partner for medical device manufacturing in the industry.  The Resilience Center of Excellence for Fill/Finish and Device Assembly & Packaging in Ohio is dedicated to supporting clients with all of their drug product fill/finish and medical device manufacturing needs. 📢 Discover our comprehensive drug product capabilities here: https://hubs.ly/Q02DL66f0  🔎 Learn more about ISO 13485 here: https://hubs.ly/Q02DLf3H0

New on the blog: What does collaboration look like across the Resilience network? Leaders in our process & analytical development (PAD) team and GMP manufacturing team speak about how these two teams collaborate extensively in order to deliver best-in-class viral vector development and manufacturing services. Hear from Kyle Anderson, Director of MSAT at Resilience RTP, North Carolina & Xiaotong Fu, Head of Downstream Process Development and Pilot Operations at Resilience Boston, Massachusetts. Watch or read the full interview here: https://hubs.ly/Q02DCpqP0 #genetherapy